Literature DB >> 12021198

Inactivation of the GR in the nervous system affects energy accumulation.

Christoph Kellendonk1, Sandra Eiden, Oliver Kretz, Günther Schütz, Ingrid Schmidt, François Tronche, Eckhart Simon.   

Abstract

The homeostatic regulation of body weight protects the organism from the negative consequences of starvation and obesity. Glucocorticoids (GCs) modulate this regulation, although the underlying mechanisms remain unclear. To address the role of central GRs in the regulation of energy balance, we studied mice in which GRs have selectively been inactivated in the nervous system. Mutant mice display marked growth retardation. During suckling age this is associated with normal fat deposition causing a 60% temporary increase of percent body fat, compared with control littermates. After weaning, fat and protein depositions are reduced so that adults are both smaller and leaner than their controls. Decreased food intake and, after weaning, reduced metabolic efficiency account for these developmental disturbances. Plasma levels of leptin and insulin, two important energy balance regulators, are elevated in young mutants but normal in adults. Leptin/body fat ratio is higher at all ages, suggesting disturbed control of circulating leptin as a consequence of chronically elevated GC levels in mutant animals. Adult mutants display increased hypothalamic CRH and NPY levels, but peptide levels of melanin concentrating hormone and Orexin A and B are unchanged. The increased levels of plasma GCs and hypothalamic CRH may act as catabolic signals most likely leading to persistently reduced energy accumulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021198     DOI: 10.1210/endo.143.6.8853

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

Review 1.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

Review 2.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

Review 3.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 4.  Are BDNF and glucocorticoid activities calibrated?

Authors:  F Jeanneteau; M V Chao
Journal:  Neuroscience       Date:  2012-09-26       Impact factor: 3.590

Review 5.  Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.

Authors:  Gloria Laryea; Lisa Muglia; Melinda Arnett; Louis J Muglia
Journal:  Front Neuroendocrinol       Date:  2014-09-27       Impact factor: 8.606

6.  Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.

Authors:  Kuixing Zhang; Fangwen Rao; Jose Pablo Miramontes-Gonzalez; C Makena Hightower; Brian Vaught; Yuhong Chen; Tiffany A Greenwood; Andrew J Schork; Lei Wang; Manjula Mahata; Mats Stridsberg; Srikrishna Khandrika; Nilima Biswas; Maple M Fung; Jill Waalen; Rita P Middelberg; Andrew C Heath; Grant W Montgomery; Nicholas G Martin; John B Whitfield; Dewleen G Baker; Nicholas J Schork; Caroline M Nievergelt; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2012-09-26       Impact factor: 24.094

7.  Early neuroendocrine alterations in female rats following a diet moderately enriched in fat.

Authors:  George Soulis; Efthimia Kitraki; Kyriaki Gerozissis
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

Review 8.  Revisiting the Stress Concept: Implications for Affective Disorders.

Authors:  Bruce S McEwen; Huda Akil
Journal:  J Neurosci       Date:  2020-01-02       Impact factor: 6.167

9.  Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.

Authors:  Z Michailidou; R N Carter; E Marshall; H G Sutherland; D G Brownstein; E Owen; K Cockett; V Kelly; L Ramage; E A S Al-Dujaili; M Ross; I Maraki; K Newton; M C Holmes; J R Seckl; N M Morton; C J Kenyon; K E Chapman
Journal:  FASEB J       Date:  2008-08-12       Impact factor: 5.191

10.  Build-ups in the supply chain of the brain: on the neuroenergetic cause of obesity and type 2 diabetes mellitus.

Authors:  Achim Peters; Dirk Langemann
Journal:  Front Neuroenergetics       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.